Dec 20, 2024 | Defective Drugs, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab) has gained attention as a groundbreaking treatment for Thyroid Eye Disease (TED), a rare autoimmune condition that causes inflammation and tissue expansion around the eyes. Approved by the U.S. Food and Drug Administration (FDA) in 2020, Tepezza...
Nov 27, 2024 | Children's Product Liability, Crush Injuries, Defective Drugs, Explosion, Gas Leak Injuries, Natural Gas Explosions, Offshore Accident, Personal Injury, Product Liability, Tepezza Injuries
Tepezza, a medication approved by the FDA in 2020 for the treatment of thyroid eye disease (TED), has been a game-changer for individuals suffering from this rare and debilitating condition. However, alongside its success in managing symptoms of TED, growing concerns...
Oct 28, 2024 | Defective Drugs, Defective Product, Product Liability, Tepezza Injuries
Tepezza, a medication originally intended to treat thyroid eye disease (TED), has recently been linked to serious hearing complications, including permanent hearing loss, tinnitus, and other auditory issues. Although Tepezza was granted fast-track approval by the FDA...
Aug 20, 2024 | Defective Drugs, Defective Medical Device, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab-trbw) is a breakthrough medication used to treat thyroid eye disease (TED), a rare condition that causes inflammation and bulging of the eyes. Tepezza was approved by the U.S. Food and Drug Administration (FDA) in January 2020 and has been...
